Available online on 15.01.2021 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

© 2011-21, publisher and licensee JDDT, This is an Open Access article which permits unrestricted non-commercial use(CC By-NC), provided the original work is properly cited

Open  Access Full Text Article                                                                                                          Review Article

Methylcobalamine (Vitamin B12): Water Soluble Vitamin with Various Pharmacological Aspect

Roopesh Kumar Yadav, Sudhanshu Mishra, Deepti Jain

School of Pharmaceutical Science, Rajiv Gandhi Prodyogiki Viswavidyalaya, Bhopal, India

 

Article Info:

___________________________________________________

Article History:

Received 06 Oct 2020;     

Review Completed 19 Dec 2020

Accepted 27 Dec 2020;  

Available online 15 Jan 2021 

________________________________

Cite this article as:

Yadav RK, Mishra S, Jain D, Methylcobalamine (Vitamin B12): Water Soluble Vitamin with Various Pharmacological Aspect, Journal of Drug Delivery and Therapeutics. 2021; 11(1):130-137                                DOI: http://dx.doi.org/10.22270/jddt.v11i1.4488           ___________________________________________________      

*Address for Correspondence: 

Sudhanshu Mishra, Assistant Professor, Dr M C Saxena College of Pharmacy, IIM Road Lucknow, India

Abstract

_______________________________________________________________________________________________

Vitamin B12 is a water-soluble vitamin that plays a key role in the brain's proper functioning and nervous system, in blood flow, and in reducing weakness and tiredness. In their food, most people get adequate vitamin B12, but in some health conditions (e.g. inadequate sleep, stomach/intestinal disorders, inflammation, cancer), there could be a shortage. If left unchecked, severe Vitamin B12 deficiency results in anemia and nerve damage. Vitamin B12 deficiency is typically treated using parenteral and oral dosage formulations, but absorption and compliance problems are involved with these routes of administration. Most significantly, the function of this missing intrinsic factor has been shown to assist in vitamin B12 absorption and a deficiency known as pernicious anaemia. Vitamin B12 is only partially absorbed when delivered by mouth to patients with pernicious anemia, but hematologically re-absorbed in patients with pernicious anemia. Parenteral administration of the extrinsic element will treat pernicious anaemia satisfactorily. There are several roles and advantages of vitamin B 12 in the human body with therapeutic effects also.

Keywords: Water Soluble Vitamins, Methylcobalamine, Vitamin B12, Pernicious Anaemia.

 


INTRODUCTION-

Although they serve many roles in the body, vitamins and minerals are fundamental supplements. There is a barely recognizable distinction between getting enough (which is solid) of these supplements and getting too much (which create overdose). The only way to get sufficient proportions of the vitamins and minerals required by our body remains to eat a solid regimen.1 Vitamins and minerals are seen as important nutrients because they have diverse functions in many ways, such as assisting in bone metabolism, wound healing, and building up our body structure, and even converting nourishment into vitality and restoring cell damage.2

Types of Vitamins

Fat-soluble vitamin- The adipose tissues of the body and the liver store fat-soluble vitamins. The A, D, E, and K vitamins are fat-soluble.3 These are less demanding to store than water-soluble vitamins, and they will remain in storage form in the body for a long amount of time, and a few months in some cases. In the digestive tract, fat-soluble vitamins are absorbed with the aid of fats or lipids.

Water-soluble vitamin-Vitamins that are water-soluble do not survive in the body for a long time. They can't be processed by the body and they get released from urination. Water-dissolvable vitamins are expelled more often along these lines than fat-solvent ones. Water solvents are vitamin C and B vitamins.4

Vitamin B12 is a water-soluble vitamin that plays a crucial role in the proper functioning of the brain and nervous system, blood production, and stress and fatigue control. 5,6

Healthy diet sources of vitamin B-12 include: milk products such as milk, cheese and yogurt, beef, fish, chicken, eggs, certain nutritional yeast products and mushrooms, certain kinds of soy milk, and breakfast cereals are enriched with vitamin B-12. Before active therapy is needed, it is often best to sustain a balanced diet and consume healthy quantities of nutrients. For a balanced diet, the signs of malnutrition are easily eroded.7,8

Benefits of Vitamin-B12

Absorption of Vitamin B12- It is protein-bound as humans take vitamin B12 orally. There is also some preliminary evidence that unbound B12 can be actively absorbed in higher rates through the membranes under the tongue than through passive diffusion in the digestive tract, especially when combined with an absorption enhancer.11 When the protein-B12 complex reaches the intestine, the stomach secretes acids and enzymes that separate B12 from the protein. Another protein that takes up and brings B12 through the small intestine and the stomach is R-protein (aka cobalophilin, haptocorrin, and transcobalamin I). The stomach cells also produce a protein called intrinsic factor (IF) that passes to the small intestine (R-protein is found in saliva and stomach). The cobalamins then take the final part of the small intestine, the ileum, to the intrinsic portion. 12 Through passive diffusion, certain inactive B12 analogs are most likely absorbed. About 60 percent of the overall volume of B12 in the body is contained in the liver and 30 percent is stored in the muscles. People typically secrete 1.4 μg/day of B12 through their bile through their small intestines. It binds to transcobalamin II-II after B12 is absorbed into the intestinal cells (TC2). Transcobalamin II captures B12 and passes it to other body tissues via the blood and cerebrospinal fluid. While B12 is transferred to cells by transcobalamin II, haptocorrin is present in around 3/4 of B12 in the blood (aka transcobalamin I and cobalophilin). B12 is released from TC2 in the form of hydroxocobalamin until the B12-TC2 complex enters the cell where it is required.13 It is then converted into methylcobalamin or adenosylcobalamin and used by its respective enzymes. Transcobalamin II also transports B12 to the liver for transcobalamin III storage. Excess B12 is excreted in the urine. This usually occurs only after injection of B12.14

STRUCTURAL CHARACTERISTICS AND CHEMISTRY OF VITAMIN B12-

Vitamin B12 is a class of cobalt and corrin ring molecules that possess vitamin activity. The sixth coordination site of the corrin ring is either a cyano group (-CN), a hydroxyl group (-OH), a methyl group (-CH-) or a 5'-deoxyadenosine group, creating four forms of vitamin B, including, cyanocobalamin, hydroxocobalamin, methylcobalamin, and adenosylcobalamin.15,16


 

 

Figure 1:  Structure of Vitamin B12

 


Solubility: Solubilized in organic solvents that are expelled with inert gas, such as ethanol and DMSO.17 The solubility of vitamin B12 is approximately 10 and 75 mg/ml, respectively, in these solvents. In water, vitamin B12 is also soluble at a concentration of 50 mg/ml.18

Stability/Shelf Life:  Light-sensitive, Hygroscopic; when exposed to air, may absorb about 12 % water.19

Pharmacokinetics-

Absorption: Readily absorbed in ileum and sublingual routes by passive diffusion. Dietary vitamin B12 is present in conjunction with food proteins and must be released inside the gastric lumen at low pH exposure to promote absorption in the small intestine. Individuals intake roughly 2.4 μg of vitamin B12 every day, of which about 50-60% is absorbed.20,21

Protein binding- Very high.

Metabolism: Occurred in the liver.

Biological half-life: 6 days.

Elimination: Urine/Bile

TYPES OF FORMULATIONS USED FOR VITAMIN B12 DELIVERY-

There is a various formulation used to reduce the risk from the deficiency of vitamin B12 like Mucoadhesive buccal tablets, Microencapsules, Lozenges, Liposomes, Buccal films, Nasal Spray, Intranasal drop, Topical microemulsion, Oral Spray, gelatin compositions (for parenteral), pen (inhaler), buccal mucoadhesive hydrogel films and toothpaste, etc. The following table no 1.0 include the different approaches of vitamin B12 in detail-22-28


 

Table 1: Comparative Table of Various Approaches of Vitamin B12

Formulations

Method of preparation

Formulation Ingredients

Characterization method

Advantages

Disadvantages

Bioavailability

Mucoadhesive                  buccal tablets

 

Direct  compression

 

hydroxypropyl methyl cellulose (HPMC), carbopol 971p (CP971p), and chitosan (Cs)

Thickness, weight,   drug content, hardness, friability,   surface pH, In vitro drug release, and mucoadhesion

Rapid onset of action, elevated patient acceptability, administration, and dose removal is easy.

Low effectiveness in terms of flavor, irritation, low permeability, and patient acceptability. Less surface area also. 

up to 2.7-

folds that of

Neurotone

 I.M.injection

Microencapsulation

Spray-drying technique

 

Modified chitosan, Vitamin B-12, Deionised water

Scanning Electron Microscopy, particle size,UV spectrophotometric method , release and its stability

 

Improving the stability of nutrition, preventing ingredient reactions and decay. The coating matrix essentially separates particles and prevents them from contacting one another.

High material loss, Sustained-release preparations. Time-consuming. , Suitable to larger particles.

 

Microencapsulation

Emulsion   technique

Vitamin B-12, PEG - 6000, Shellac , Liquid Paraffin, Acetone, Cyclohexane, Mannitol, Tween 80

Strength, Percentage Yield, Dissolution Rate, Accelerated stability testing

 

Higher stability, prevent their deterioration, preventing ingredient interactions

 

 

Hard  gelatin capsules

 

10 mg vitamin B12,10g vitamin B1,10 g riboflavin, 50g niacinamide,5 g calcium pantothenate, 4.5 grains desiccated whole liver, 1980 g of iron

Weight variation, content Uniformity Disintegration time, Dissolution time

 

tasteless, odorless, easy to administrate,

Attractive to appearance, Easy to handle and carry.

 

absorb water

 

Lozenges

1000 mcg

 

 

Folate  42%, Vitamin B-12(as Cyanocobalamin) 41,667%, Fructose, Microcrystalline Cellulose, Sorbitol, Natural Flavors, Stearic Acid (vegetable source), Magnesium Stearate (vegetable source) and Silicon Dioxide.

Particle size distribution, moisture content, flow, blend uniformity, hardness, tablet weight, thickness

Increase the retention time of the dosage form, increases bioavailability reduces gastric irritation and bypasses the first-pass metabolism.

No drinking or eating before or during use. Should not be swallowed

 

Liposomes

 

 

Phosphatidylcholines, glycerin, natural orange flavor, stevia, potassium sorbate, vitamin B12, purified water

 

Size-around 450nm positive surface charge, loading efficiency

 

Increase absorption and bioavailability

Improve their transit across the barriers of the gastrointestinal tract. Improve the therapeutic efficacy of dietary supplements

high production cost., may undergo oxidation and hydrolysis,

Shorter half-life. Lower solubility.

 

 

Buccal  films

By  positron annihilation lifetime

spectroscopy

 

vitamin B12, sodium alginate, and Carbopol 71G

 

Dissolution test, weight, thickness, surface pH, swelling index, drug content uniformity, in vitro residence time, folding endurance in vitro release, and permeation studies.

Preferable  over tablets in terms of flexibility and thinness thus being less obtrusive and more acceptable to the patient

 

Eating and drinking may become restricted, the possibility of the patient swallowing the dosage form.

 

Nasal Spray

Once weekly

 

Sodium  citrate, citric acid, and glycerin and benzalkonium chloride in purified water

pH between 4.5 and 5.5. spray pattern, Accelerated Stability at a higher temperature

Flexible and patient compliance

Irritation of nasal mucosa and can be interrupted by respiratory disorders

6.1%.

 

Intranasal

 

 

Cyanocobalamin  0.5% ,

citric acid 0.12%, sodium citrate 0.32%, glycerin 2.23%, benzalkonium chloride 0.02% and 96.79% water.

 

viscosity (less than 1000 cps), spray pattern, Accelerated Stability at a higher temperature

 

Lower viscosity avoids the GI tract and hepatic metabolism, bypasses the BBB enhancing drug bioavailability and allowing a lower therapeutic drug dose and fewer systemic side effects free of mercury compounds

Low  volume of drug that can be administered

7%

 

Nasal Spray

 

Methylcobalamin 500 (mcg)

Benzalkonium chloride 0.02 (mcg)

Glycerin  223(mcg)

Glycofurol 100(mcg)

Sodium citrate dehydrate 0.38(mcg)

Citric acid anhydrous

Water 10 (ml)

pH, Osmolarity,

drug content, appearance, a transmission rate

 

Hepatic first-pass metabolism is absent, Rapid drug absorption and quick onset of action can be achieved, the bioavailability of larger drug molecules can be improved 

Suitable for potent medicines since it is easy to spray only a small amount into the nasal cavity. There could be fewer medications with constant and regular administration.

 

 


Topical    micro-emulsion

Titration method

Stearylamine,tween80,span20,labrafil ,propylene glycol ,oleic acid and Cyanocobalamin  (Vitamin  B12) 

 

 (DSC), X-ray  diffraction,  particle  size, conductivity,  surface tension, and viscosity 

Facilitate in preparing, perfect stability, increasing speed and stability drug solubility,  controlling  drug delivery rate,  Improvement of hydrophilic and lipophilic drug bioavailability

A large concentration of surfactant and co-surfactant is necessary for stabilizing the droplets of the microemulsion.

Limited solubilizing capacity for high-melting substances 

 

Oral Spray

 

Oral Spray Methylcobalamin ,d-alpha-tocopherol , potassium sorbate,citric acid,peppermint oil, water

 

 

specific gravity 1.035 g/mL ,pH of 3.95,dencity,viscocity

Faster onset and longer duration of action. ease of administration, elimination of the first-pass metabolism

·        Taste masking is a major problem not applicable to drugs that require high large doses, not suitable for sustained‐delivery systems as it interferes with eating, drinking, and talking.

 

Gelatin   compositions

(for parenteral)

 

Distilled water, 6 g of vitamin B12, 1000 g Type A gelatin, 10 % aqueous sodium carbonate, 45 g. of benzyl alcohol

 

Sterility tests

pH of 4.5. Leaker Tests. Particulate matter testing. Sterility tests

 

Act immediately and allow the administrator to control drug delivery. , improve medication adherence.

painful, need a specialist for administration and source of infection

 

Pen (inhaler)         20-30 puffs

 

 

Vegetable Glycerin USP, Deionized Water, Organic Fruit Flavor Extract (Water, Organic Ethyl Alcohol, and Natural Flavors), Vitamin B12

Dosage control torque tests for metered inhalers,auto-injectors,

No Harmful Or Addictive Ingredients, recycle

 

·        Dehydration, headache, Nausea, Stomachache

 

Buccal   mucoadhesive hydrogel films.

 

Solvent casting technique

Chitosan, B12, Polyvinyl alcohol, polyethylene glycol 400, propylene glycol, maleic anhydride. Agar powder and mucin

Thickness, weight variation, drug content, percentage moisture uptake and moisture content, surface pH, mechanical properties, in vitro release and mucoadhesion, percentages of moisture content, percentage drug released, FTIR, drug/polymer interaction

Low  enzymatic activity, longer retention time at the absorption site

 

 

Toothpaste

(With two brushes a day 3.6 µg)

 

10% glycerin, 10% hydrated silica,30% purified water,10% sorbitol ,30% xylitol,3% carrageenan,3% sodium lauryl Sulfate,3% titanium dioxide,0.30%-1% oil of wintergreen,Methylcobalamin (Vitamin B12),

pH, Spreadability, abrasiveness, foaming ability, cleaning ability, fineness, moisture and volatile content, tube inertness,Test for F-, Pb, As, and stability studies.

Increases the risk of scratches even when you brush gently. If the enamel gets scratched, more stains may appear, and the risk of decay increases, allergic reaction to this drug is rare. 

 

 

 

 


COMMON POINTS

For the treatment of pernicious anemia, we administered oral methylcobalamin 3 times per day, which provides a total of 1000 μg of methylcobalamin daily, oral sprays of vitamin B12 delivers (0.3 mL). Common ingredients of vitamin B12 formulations are (Vitamin B12), potassium sorbate, Deionised water. The pH of all the formulations are found to be 4.5 to 6.529

STORAGE CONDITIONS

Methylcobalamin is a substance that is susceptible to light and can thus be shielded from light. In cartons, keep the formulation sealed until it is fit for use. Hold upright at a controlled room temperature of 59 °F to 86 °F (15 °C to 30 °C). Protect from the freezing of the formulation.30

COMPARISON BETWEEN VARIOUS FORMULATIONS OF VITAMIN B12

 Cost: Suggested retail prices indicate that the cost of oral Vitamin B12 therapy at a dose of one Also high compared to buccal and parenteral dosage form buccal patches are cheap compared to the other two formulations.1000 μg tablet daily is approximately equivalent to the cost of taking 500 mg of calcium and 1000 IU of Vitamin D [24]. As the dose of the drug given by oral is high, the cost is also high compared to the other two formulations. 31

Safety: Vitamin B12 injections can be dangerous in anti-coagulated patients Hypo-kalmia and cardiac arrest has been reported when megaloblastic anemia is treated intensively. Pain full and require assistance. Oral administration is safe compared to intramuscular injection but requires 1000μg-2000 μg per day. buccal patches are convenient, safe, and easy to insert and the low drug is required prolonged effect can be obtained. 32,33

Various Functions of Vitamin B12 in Human Body-

The significant reactions involved in vitamin B12 metabolism describe its critical role in several physiological processes. Vitamin B12's main purposes are summed up as follows:34


 

Figure 2: Functions of Vitamin B12 in Human Body

 

 


Deficiency and abundance of vitamin B12-

A common diagnosis, especially in older adults, is vitamin B12 deficiency. The deficiency is also attributed to gene mutations that encode essential proteins in the metabolism of cobalamin, diet (vegetarian, vegan diet) and decreased production of stomach acids needed for vitamin B12 to be absorbed. Other common causes are pernicious anemia (malabsorption of vitamin B12); atrophic gastritis; gastrectomy; Zollinger-Ellison syndrome; intestinal diseases, especially of the ileum (celiac disease, Crohn’s disease, ileitis); pancreatic insufficiency; parasitism; bacterial overgrowth; medicament use (antiepileptic agents, proton pump inhibitors, histamine receptor antagonists, metformin, antibiotics); diabetes mellitus; renal insufficiency; smoking; and alcohol abuse. Although vitamin B12 deficiency has been intensively studied, in the literature the reverse condition, abnormally high levels, is scarcely discussed. In both circumstances, elevated plasma levels (when not associated with external supply) lead to an improvement in vitamin B12 metabolism, either increased synthesis or reduced B12-binding protein clearance.35

Safety and Precautions-

CONCLUSION

The intramuscular approach is uncomfortable and requires medical dosing assistance and is very expensive since it absorbs faster, the retention time is short (fast reaction). Since the GI tract is a lipid-based membrane, oral ingestion of B12 requires a significant volume of drug, and being more hydrophobic in nature is less desirable for the absorption of vitamin B12 hydrophilic drug. From the above details, the oral route is more reliable in the treatment of pernicious anemia, improves the bioavailability of vitamin B12, and there are particular advantages to this route of drug delivery, including bypassing the first-pass effect and preventing pre-systemic removal inside the GIT.

REFERENCES

  1. Sarti F, Müller C, Iqbal J, Perera G, Laffleur F, Bernkop-Schnürch A. Development and in vivo evaluation of an oral vitamin B12 delivery system. European Journal of Pharmaceutics and Biopharmaceutics. 2013 May 1; 84(1):132-7.
  2. Narang N, Sharma J. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci. 2011; 3(Suppl 2):18-22.
  3. Lucy JA, Dingle JT. Fat-soluble vitamins and biological membranes. Nature. 1964 Oct 10; 204(4954):156-60.
  4. Arnstein HR, Simkin JL. Vitamin B12 and Protein Biosynthesis: Vitamin B12 and Biosynthesis in Rat Liver. Nature. 1959 Feb 21;183(4660):523-5.
  5. Stabler SP. Vitamin B12 deficiency. New England Journal of Medicine. 2013 Jan 10; 368(2):149-60.
  6. Vitetta L, Zhou J, Manuel R, Dal Forno S, Hall S, Rutolo D. Route and type of formulation administered influences the absorption and disposition of vitamin B12 levels in serum. Journal of functional biomaterials. 2018 Mar; 9(1):12.
  7. Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu. Rev. Nutr.. 2004 Jul 14; 24:299-326.
  8. Heilmann S, Just T, Göktas O, Hauswald B, Hüttenbrink KB, Hummel T. Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss. Laryngo-rhino-otologie. 2004 Nov 1; 83(11):729-34.
  9. Rutolo Jr DA, Hall SM, Vitetta L, Zhou Y, Coulson SM, inventors; Medlab Clinical US Inc, assignee. Transmucosal and transdermal delivery systems. United States patent application US 15/555,038. 2018 Feb 8.
  10. Smith FJ, Monto RW, Rebuck JW. B-12 Inhalation Therapy in Pernicious Anemia. Transactions of the American Clinical and Climatological Association. 1953; 64:27.
  11. Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Frontiers in Pharmacology. 2019;10.
  12. Lee ES, Yum SI, inventors; Alza Corp, assignee. Permeation enhances for transdermal drug delivery compositions, devices and methods. United States patent US 6,004,578. 1999 Dec 21.
  13. Gimsing P, Hippe E, Helleberg‐Rasmussen I, Moesgaard M, Nielsen JL, Bastrup‐Madsen P, Berlin R, Hansen T. Cobalamin forms in plasma and tissue during treatment of vitamin B12 deficiency. Scandinavian Journal of Haematology. 1982 Oct; 29(4):311-8.
  14. Motwani JG, Lipworth BJ. Clinical pharmacokinetics of drugs administered buccally and sublingually. Clinical pharmacokinetics. 1991 Aug 1; 21(2):83-94.
  15. Rozgony NR, Fang C, Kuczmarski MF, Bob H. Vitamin B12 deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial?. Journal of Nutrition for the Elderly. 2010 Feb 24; 29(1):87-99.
  16. Riepma KA, inventor. Sublingual administration of vitamin b12 dispersed in a hydrophobic continuous phase. United States patent application US 15/761,146. 2018 Sep 20.
  17. Boulos A, Desai J, Martin N, Stillman R, Udwin M, inventors; Bristol Myers Squibb Co, assignee. Vitamin formulation for cardiovascular health. United States patent US 6,914,073. 2005 Jul 5.
  18. Castelli MC, Friedman K, Sherry J, Brazzillo K, Genoble L, Bhargava P, Riley MG. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study. Clinical therapeutics. 2011 Mar 1; 33(3):358-71.
  19. Jain K, Jayanthi C, Singh M, Roopa G, Joshi H. Comparison study of vitamin-B12 for its efficacy and bioavailability of various formulations in the treatment of pernicious anemia. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7:13.
  20. Quay SC, Aprile PC, Go ZO, Sileno AP, inventors; QOL Medical LLC, assignee. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery. United States patent US 7,404,489. 2008 Jul 29.
  21. Katsogiannis I, Fikioris N, Kontogiorgis C, Constantinides T. Evaluation of liposomal B12 supplementation in a case series study.
  22. Monto RW, Rebuck JW, Brennan MJ. Inhalation And Nasal Instillation Of Crystalline B12 Therapy In Pernicious Anemia. Henry Ford Hospital Medical Journal. 1953; 1(1):15-20.
  23. Mohamad SA, Abdelkader H, Elrehany M, Mansour HF. Vitamin B12 buccoadhesive tablets: auspicious non-invasive substitute for intra muscular injection: formulation, in vitro and in vivo appraisal. Drug development and industrial pharmacy. 2019 Feb 1; 45(2):244-51.
  24. MONTO RW, REBUCK JW. Nasal instillation and inhalation of crystalline vitamin B12 in pernicious anemia. AMA Archives of Internal Medicine. 1954 Feb 1; 93(2):219-30.
  25. Rozgony NR, Fang C, Kuczmarski MF, Bob H. Vitamin B12 deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial?. Journal of Nutrition for the Elderly. 2010 Feb 24; 29(1):87-99.
  26. Chan CQ, Low LL, Lee KH. Oral vitamin B12 replacement for the treatment of pernicious anemia. Frontiers in medicine. 2016 Aug 23; 3:38.
  27. Vidal‐Alaball J, Butler C, Cannings‐John R, Goringe A, Hood K, McCaddon A, McDowell I, Papaioannou A. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews. 2005.
  28. Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, Garrido-Elustondo S, del Cura-González I, Martín-Fernández J, Escortell-Mayor E, Rodríguez-Salvanés F, García-Solano M, González-González R, Martín-de la Sierra MÁ. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health. 2012 Dec; 12(1):1-1..
  29. Mohamad SA, Abdelkader H, Elrehany M, Mansour HF. Vitamin B12 buccoadhesive tablets: auspicious non-invasive substitute for intra muscular injection: formulation, in vitro and in vivo appraisal. Drug development and industrial pharmacy. 2019 Feb 1; 45(2):244-51..
  30. Riepma KA, inventor. Sublingual administration of vitamin b12 dispersed in a hydrophobic continuous phase. United States patent application US 15/761,146. 2018 Sep 20.
  31. Donangelo CM, Trugo NM, Koury JC, Barreto SM, Freitas LA, Feldheim W, Barth C. Iron, zinc, folate and vitamin B12 nutritional status and milk composition of low-income Brazilian mothers. European journal of clinical nutrition. 1989 Apr; 43(4):253.
  32. Sivakumar T. A Nerve Conduction study in Hypothyroid Patients with Symptomatic Vs Asymptomatic Peripheral Neuropathy in Correlation with Serum VIT B12 Level(Doctoral dissertation, KAP Viswanatham Government Medical College, Tiruchirappalli).
  33. Akhtar MA. VITAMINS: USES AND MISUSES. Pakistan Armed Forces Medical Journal. 2007 Jun 30; 57(1):2-4.
  34. Blakeley M, Sobczyńska-Malefora A, Carpenter G. The Origins of Salivary Vitamin A, Vitamin B12 and Vitamin D-Binding Proteins. Nutrients. 2020 Dec; 12(12):3838.
  35. Kalimeri M, Leek F, Wang NX, Koh HR, Roy NC, Cameron‐Smith D, Kruger MC, Henry CJ, Totman JJ. Folate and Vitamin B‐12 Status Is Associated With Bone Mineral Density and Hip Strength of Postmenopausal Chinese‐Singaporean Women. JBMR plus. 2020 Oct; 4(10):e10399.
  36. Ao M, Inuiya N, Ohta J, Kurose S, Takaoka H, Abe Y, Niki N, Inoue S, Tanaka S, Miyawaki T, Tanaka K. Relationship between homocysteine, folate, vitamin B12 and physical performance in the institutionalized elderly. Journal of nutritional science and vitaminology. 2019 Feb 28; 65(1):1-7.